Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
21.47
+0.97 (4.73%)
At close: Apr 2, 2026, 4:00 PM EDT
21.47
0.00 (0.00%)
After-hours: Apr 2, 2026, 4:10 PM EDT
Bicara Therapeutics Employees
Bicara Therapeutics had 103 employees as of December 31, 2025. The number of employees increased by 48 or 87.27% compared to the previous year.
Employees
103
Change (1Y)
48
Growth (1Y)
87.27%
Revenue / Employee
n/a
Profits / Employee
-$1,339,320
Market Cap
1.41B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 103 | 48 | 87.27% |
| Dec 31, 2024 | 55 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Novavax | 749 |
| Immatics | 711 |
| Vir Biotechnology | 367 |
| Wave Life Sciences | 317 |
| Precigen | 160 |
| Monte Rosa Therapeutics | 150 |
| Maze Therapeutics | 141 |
BCAX News
- 2 days ago - Bicara: Maintaining 'Buy' Rating On Ficerafusp Alfa Phase 3 Advancement - Seeking Alpha
- 3 days ago - Bicara Therapeutics Inc. (BCAX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 10 days ago - Bicara Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Business Updates on March 30, 2026, at 8:30 AM ET - GlobeNewsWire
- 22 days ago - Bicara Therapeutics Inc. (BCAX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Bicara Therapeutics Announces Closing of Oversubscribed Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 5 weeks ago - Bicara Therapeutics Inc. (BCAX) Discusses Ficerafusp Alfa Clinical Data and Less Frequent Dosing in First-Line HPV-Negative Head and Neck Squamous Cell Carcinoma Transcript - Seeking Alpha